The Australian biopharmaceutical firm’s American Depositary Shares debut on Nasdaq following SEC effectiveness declaration.
CLINUVEL Pharmaceuticals’ American Depositary Shares (ADS) start trading on the Nasdaq Stock Market today under the ticker symbol CUVL. The move follows a July 17 declaration of effectiveness by the U.S. Securities and Exchange Commission.
The company, previously listed on the OTC markets under tickers CLVLY and CLVLF, upgrades its U.S. listing to enhance visibility and liquidity. No new shares were issued for this transition, according to the announcement.
Trading commenced at market open, though no immediate price reaction details were provided.